SCHEMBL7360766

SCHEMBL7360766

COC(=O)Cc1ccc(N(C)C)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.59
CYP4A11 Q02928 1/20 0.59
ALDH1A1 P00352 7/20 0.53
HPGD P15428 3/20 0.53
GAA P10253 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
TSHR P16473 2/20 0.53
MAPK1 P28482 2/20 0.53
NPC1 O15118 2/20 0.53
KDM4E B2RXH2 2/20 0.53
HSD17B10 Q99714 1/20 0.53
HDAC1 Q13547 2/20 0.51
MAPT P10636 3/20 0.49
GFER P55789 2/20 0.49
HDAC6 Q9UBN7 1/20 0.49
HSP90AB1 P08238 1/20 0.48
CYP3A4 P08684 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
KMT2A Q03164 1/20 0.48
CNR2 P34972 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4113212 0.85 CYP4F2 (0.76) CYP4F2CYP4A11ALDH1A1HPGDGAA
SCHEMBL512626 0.81 CYP4Z1 (0.55) CYP4F2CYP4A11ALDH1A1HPGDGAA
SCHEMBL11234424 0.81 KMT2A (0.53) ALDH1A1HPGDGAASMN1; SMN2TSHR
SCHEMBL8142192 0.81 ALDH1A1 (0.50) CYP4F2CYP4A11ALDH1A1HPGDGAA
SCHEMBL17653822 0.81 CYP4F2 (0.51) CYP4F2CYP4A11ALDH1A1HPGDGAA
SCHEMBL17114422 0.80 CYP4F2 (0.50) CYP4F2CYP4A11ALDH1A1GAASMN1; SMN2
SCHEMBL10611271 0.79 ALDH1A1 (0.56) ALDH1A1HPGDGAASMN1; SMN2TSHR
SCHEMBL2568449 0.79 HDAC1 (0.58) ALDH1A1TSHRMAPK1HDAC1HDAC6
SCHEMBL7472261 0.79 CYP4F2 (0.62) CYP4F2CYP4A11ALDH1A1HPGDGAA
SCHEMBL11031784 0.79 ALDH1A1 (0.44) ALDH1A1HPGDGAASMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117255814-A Catechol-containing film material 米塞尔聚合物公司 2023-12-19 CN disclosed
EP-1849796-B1 ANTI-PENICILLIN RESISTANT PNEUMOCOCCI AGENT AND NOVEL 16-MEMBERED RING MACROLIDE DERIVATIVE MICROBIAL CHEM RES FOUND (JP) 2014-11-05 EP disclosed
US-8507453-B2 Anti-penicillin resistant pneumococci agent and novel 16-membered macrolide derivative MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) 2013-08-13 US disclosed
US-8507453-B2 Anti-penicillin resistant pneumococci agent and novel 16-membered macrolide derivative MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) 2013-08-13 US disclosed
CN-101400657-B Polycyclic cinnamamide derivative ESAI R & D MAN CO LTD 2012-05-30 CN disclosed
US-20120015896-A1 Anti-Penicillin Resistant Pneumococci Agent and Novel 16-Membered Macrolide Derivative MICROBIAL CHEMISTRY RESEARCH FOUNDATION 2012-01-19 US disclosed
US-20120015896-A1 Anti-Penicillin Resistant Pneumococci Agent and Novel 16-Membered Macrolide Derivative MICROBIAL CHEMISTRY RESEARCH FOUNDATION 2012-01-19 US disclosed
US-8053418-B2 Anti-penicillin resistant pneumococci agent and novel 16-membered macrolide derivative MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) 2011-11-08 US disclosed
US-8053418-B2 Anti-penicillin resistant pneumococci agent and novel 16-membered macrolide derivative MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) 2011-11-08 US disclosed
CN-101400657-A Polycyclic cinnamamide derivative ESAI R & D MAN CO LTD (JP) 2009-04-01 CN disclosed
US-20080300388-A1 Anti-Penicillin Resistant Pneumococci Agent and Novel 16-Membered Macrolide Derivative MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) 2008-12-04 US disclosed
US-20080300388-A1 Anti-Penicillin Resistant Pneumococci Agent and Novel 16-Membered Macrolide Derivative MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) 2008-12-04 US disclosed
US-7250525-B2 Stilbene derivatives and their use for binding and imaging amyloid plaques THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2007-07-31 US disclosed
US-6458796-B1 METHOD OF TREATING CARDIOVASCULAR DISORDERS, THROMBOEMBOLIC DISORDERS AND ISCHAEMIAS, AND UROGENITAL SYSTEM DISORDERS, COMPRISING ADMINISTERING TO MAMMALS BAYER AKTIENGESELLSCHAFT (DE) 2002-10-01 US disclosed
US-4778834-A COATING WITH SILICEOUS MATERIAL AND ORGANOSILANE, THEN POLYMERIZATION STERLING DRUG INC. (US) 1988-10-18 US disclosed
US-4439554-A DENTISTRY, ORTHOPEDICS AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) 1984-03-27 US disclosed
US-4390714-A DENTISTRY AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) 1983-06-28 US disclosed
US-4243763-A DENTISTRY AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) 1981-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015896-A1 Anti-Penicillin Resistant Pneumococci Agent and Novel 16-Membered Macrolide Derivative PWWP2B, BRWD1, BAZ1A CYP4F2 4616/4885CYP4A11 3942/4885ALDH1A1 4196/4885
US-20080300388-A1 Anti-Penicillin Resistant Pneumococci Agent and Novel 16-Membered Macrolide Derivative PWWP2B, BRWD1, BAZ1A CYP4F2 4616/4885CYP4A11 3942/4885ALDH1A1 4196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.